NYSE, CBM - Cambrex Corp
Cambrex Corporation (the "Company" or "Cambrex"), a Delaware corporation,
began business in December 1981. Cambrex is a life sciences company dedicated to
growing its portfolio of commercial small molecule therapeutics and providing
products and services that accelerate and improve the discovery and
commercialization of new therapeutics. The Company primarily supplies its
products and services worldwide to pharmaceutical and generic drug companies.
Cambrex has three operating segments, which are manufacturing facilities, that
have been aggregated as one reportable segment. ...
Read SEC Filing on NASDAQ.com »